Wiredja Online News Logo

WiredJa Online News

Wiredja Online News Logo

WiredJa Online News

Cuba develops new Sovereign 01 A vaccine candidate, an added bonus to fight Covid-19

Havana, Mar 5 - Cuba is not waiting on the beneficience of US President Joe Biden to ease the crushing  economic sanctions to determine whether it will be able to access Covid-19 vaccines. Its Development of four vaccine candidates against Covid-19 in a short time is a feat of Cuba's biotechnology, but reaching a fifth is an added bonus to the Cuban population.

Additional Info

  • Countries Cuba
  • Published in Health

CUBA'S COVID-19 Vaccine, Soberana 02 could be ready by late April

HAVANA, Cuba, February 27,  --  Forced by punishing economic sanctions from the United States to come up with its own vaccine against the COVID-19 virus, Cuba could be one of the first nations to immunize its entire population, when it becomes available in late April.

Additional Info

  • Countries Cuba
  • Published in Health

CUBA Expands clinical trials for its COVID-19 vaccine Soberana 02

Cuba has expanded phase II B clinical trials of that country's anti-COVID-19 candidate vaccine Soberana 02 with volunteers between 19 and 80 years of age, began at the 19 de Abril and No.1 Polyclinics, in the Havana municipalities of Plaza de la Revolución and La Lisa, respectively.

Additional Info

  • Countries Cuba
  • Published in Health

A vaccine that could block mosquitoes from transmitting malaria

Is it possible to eradicate malaria?   It is a question with which many researchers have grappled, and many ideas have been proposed. The reason malaria has garnered so much attention is that it is one of the deadliest diseases, infecting 200 million people and killing more than 500,000 annually, with infants in Africa suffering the majority of fatalities.

Additional Info

  • Countries United_States
  • Published in Health

CONGO | DRC may provide model for containing future Ebola outbreaks

When the Ebola virus struck West Africa in 2014, it resisted early attempts at control. It took more than two years to overcome, claiming more than 11,000 lives. Volunteers from the West who were infected were flown home and treated with experimental therapies, while those on the ground in Sierra Leone, Liberia and Guinea were treated in camps set up to deal with the disease.

Additional Info

  • Countries Africa
  • Published in Health

Novel tool to may lead to Zika vaccines

Scientists have developed a way to replicate the Zika virus, stripping it of the genes that make the virus infectious, an advance that may lower the safety risk involved in working with it and pave the way for vaccine development.

Additional Info

  • Countries None
  • Published in Health
Subscribe to this RSS feed